Peer Review History
| Original SubmissionMarch 30, 2025 |
|---|
|
Response to ReviewersRevised Manuscript with Track ChangesManuscript Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 Additional Editor Comments:Journal Requirements: 1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019. 2) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. Reviewers' comments: Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: In Background (page 2), the authors didn't explain about the reason of the "interventions particularly for facial cleanliness and environmental improvement have been sub-optimally adopted" In Introduction (page 6), the authors have to explain, in depth, the usefulness of the results. The authors only mentioned: "The results will inform......through the identified determinants of adoption" In Methods (page 6), the study employed the RE-AIM/PRISM but it's not clear if there some evidence of the use of RE-AIM/PRISM in trachoma's studies The authors also mentioned the following: "it is one of the understudied areas in this field". I recommend to explain the idea in introduction In sampling and participant recruitment (page 8) stratified random sampling method was used so it's necessary to estimate the sample size calculation with design effect I suggest to explain a little more some variables like training, position held, length of service, etc before the results. e.g.1. perceived intervention complexity, how it complexity define? e.g.2. transport availability, and the options are not available, rarely available and readily available. what does mean rarely? once, twice a month? In data collection (page 9), the authors mentioned that the quantitative data was collected by the principal investigator with help of 3 research assistants. I suggest to introduce more information about the research assistants, e.g. they trained before the study's execution Reviewer #2: The main issue is that the sampling strategy was confusing. Is this a random sample? Reviewer #3: The objectives of the study are clearly articulated with a clear testable hypothesis stated The study design is appropriate to address the study objectives The targeted and sampled population is clearly described and appropriate for the hypothesis being tested The sample size is sufficient to ensure adequate power to address the hypothesis being tested The study applied the correct statistical analysis to support conclusions The study has no concerns about ethical or regulatory requirements. All ethical or regulatory requirements were met ********** Results: -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: I don't understand why the authors show the characteristics of the participants in two tables. Is there some reason? I recommend to write the main results (page 10). e.g. 34.79% were from health posts. I will change this instead 51.55 were from rural health centre Reviewer #2: Yes Reviewer #3: The analysis which was conducted matches the analysis plan The study results are clearly and fully presented The figures (Tables, Images) included in the study are sufficient quality for clarity ********** Conclusions: -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: The discussion is too long and it's not clear about the information that the authors want to give to the readers. e.g. Our findings are similar to those of Tsang et al (2021) perhaps due to the fact that both research were conducted in rural areas and the study populations were very similar (page 22). The majority of the studies about trachoma were developed in rural setting so the information gave for the authors is not relevant Reviewer #2: Generally yes though in the limitations paragraph I would comment that these results may not be generalizable outside these districts of Zambia, and I would limit any conclusions only to the study area and not try to extrapolate to other settings. Reviewer #3: The conclusions are supported by the data presented, though the conclusion should be strengthened and rephrased to focus on key information from the results presented The limitations of analysis should be clearly described The authors have discussed how these data can be helpful to advance our understanding of the topic under study Public health relevance has been addressed ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: I suggest only use the variables that are really important to the study. I think there are so many variables that it could create a confusion to the reader Reviewer #2: (No Response) Reviewer #3: The authors should make minor revisions ********** Summary and General Comments: Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: I will review the regression analysis carefully, as the authors used stratified random sampling. This sampling design requires adjustments in the regression model to avoid underestimating the confidence intervals. Maybe, Incorporate strata and cluster variables into the model. Reviewer #2: Line 33: what intervention? It’s not clear what these percentages refer to Line 34: not sure the lower odds in Kaoma and Shangombo need to be in the abstract. That seems like knowledge that would be important for local policymakers but this paper is presumably being written to share more broadly generalizable knowledge. I would delete that sentence. (And probably the final sentence of the conclusion) Line 40: similar comment, but need to specify what adoption is, and how it is defined. Is this self-reported adoption? What components were adopted? Line 80: “core components”: is this promoted by the government in some official way? Is this a more informal assessment by the authors based on activities of NGOs? Please more clearly state how these core components have been defined. Line 81: Are IEC materials a standardized set of materials made by the government? Or by an NGO? Or does this just mean any type of materials that an individual health center might have made. Line 136: “full SAFE strategy”: who makes this decision / who implements this. Is this from the government/MOH? Is this NGOs? Line 156: the methods for stratified random sampling were not clear. In line 160, does “representative” = “random” (and if so, please use the word random). I wondered if 24 health facilities were randomly selected from the total pool of 52 health facilities using probability proportional to size sampling, and then if within these 24 selected facilities systematic sampling was employed. (but no details are given about how the systematic sampling was actually done, and my summary above is not actually stated anywhere but just my hypothesis of what was done.) Please be more explicit about the sampling. Line 222: how was “knowledgeable about facial and environmental hygiene promotion” defined? Is this knowledge? Or familiarity? Line 225: how was a “positive attitude” defined, or how was the question asked? (If as stated in Table 1b, I would include this in the text as well) Table 1b: “perceived relevance of F and E”: relevance for what? Relevant for trachoma control? Relevant as an activity that the health center should be doing? Table 1b: what does “incentives” mean. That the workers are paid extra to do hygiene promotion above and beyond their salary? Table 1c: spell out full words of IEC in footnote or caption Table 2: I believe the AOR was constructed from all variables in the table after applying a backwards stepwise approach. (A) what was the p-value threshold to remove a variable from the model? (maybe include this in the methods) (B) in the table caption or footnote I would include that the adjusted model was selected using a backwards stepwise approach. (C) in the table caption please specify what the outcome is for the ORs (adoption of promotion activities I believe?). Line 288: “determinants” makes this sound like a causal relationship. But here only an association has been found. I would change to “The main factors associated with…” or something like that. Also: I did not scour the text after noticing this, but please read through and make sure that the text uses words that expresses only a cross-sectional association, and not a causal relationship. Line 391: trachoma prevalence was not reported here. A citation should be given, and also a little more detail. (What does a “decrease in trachoma prevalence” mean? Between which years? According to which surveys? Does this mean TF?) Line 299: “there is a need to increase funding”: I am not sure I agree. If I were a donor I would want evidence that implementing F&E is effective. Currently there are very few interventional studies that have shown F&E to be effective. Almost all the evidence comes from observational studies. If health workers are not adopting hygiene promotion but hygiene promotion does not work, then why should funders devote more money to it? Also, the results of this one study may not be relevant to other places. You could consider some caveats to this sentence, eg: “The results of this study demonstrate a need for increased funding and training in facial and environmental hygiene promotion in the study area, given the district/zone/federal stated plans/commitment/goals for hygiene programming.” Or something like that, which would be accurate for the Zambian setting. Fig 1: these are petty comments, and if it is very difficult to change I would not worry about it, but for your next paper consider: (a) no need for any decimal places on y axis; (b) third dimension on bar graphs conveying no information and thus should be dropped. Reviewer #3: Under key words – consider rephrasing to Determinants; Adoption; Facial and environmental hygiene promotion; SAFE strategy; Trachoma elimination; Western Province, Zambia as key words Line 22 – consider including this statement; In Zambia, Western province is the most affected province with trachoma. Ref this in the main body1-3Reference this work to justify selection of Western province for this research 1. Mwale C, Mboni C, Saasa N, et al.; Assessing trachoma elimination progress in districts with persistent trachoma, Western Province, Zambia. International health 2025:ihaf041. 2. Mwale C, Mumbi W, Funjika M, et al.; Prevalence of trachoma in 47 administrative districts of Zambia: results of 32 population-based prevalence surveys. Ophthalmic epidemiology 2018;25(sup1):171-180. 3. Mwale C, Mulamba M, Chama E, et al.; Assessment of outcomes of the patients undergoing surgery for Trachomatous Trichiasis, Western Province, Zambia. Medical Journal of Zambia 2025;52(3):332-339. Line 1 – edit to read Determinants of adoption of facial and environmental hygiene promotion in the ‘SAFE strategy’ for trachoma elimination in Western Province, Zambia – a cross-sectional study or Determinants of adoption of facial and environmental hygiene promotion in the ‘SAFE strategy’ for trachoma elimination in Western Province, Zambia Line 22 – Rephrase to The SAFE strategy (Surgery, Antibiotics, Facial Cleanliness 23 and Environmental Improvement) is recommended by WHO for elimination of trachoma. Line 52 – elimination of trachoma in endemic communities Line 63 – elimination program officers and stakeholders Ine 72, include references 1 and 2 above Line 102 - help trachoma elimination program implementers identify possible solutions to enhance adoption Line 152 - equation, n ≥ (Z2 p [1-p])/e2 where, n is the sample size, z is the selected critical value of desired – state the value of each parameter used in the equation Line 147 - Sampling – where facility in charges included among participants, if not why? Line 389 - This study found that Shangombo, a district which did not widely adopt community demonstration for correct face and hand washing methods did not record a significant reduction in trachoma prevalence. – ref 1 above Line 392 interventions may lead to persistent active trachoma – ref 1 above Line 398 – what is MDA, which appears in the conclusion ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No Figure resubmission:Reproducibility:--> -->-->To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols-->?>
|
| Revision 1 |
|
Dear Ms. Kasongo, We are pleased to inform you that your manuscript 'Factors associated with health worker adoption of facial and environmental hygiene promotion in the ‘SAFE strategy’ for trachoma elimination in Western Province, Zambia.' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Josh M Colston, Ph.D. Academic Editor PLOS Neglected Tropical Diseases Amy Morrison Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 *********************************************************** Thank you for your resubmission, and congratulations on an excellent study and article that is well worthy of publication in PLOS NTDs. p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none |
| Formally Accepted |
|
Dear Kasongo, We are delighted to inform you that your manuscript, " Factors associated with health worker adoption of facial and environmental hygiene promotion in the ‘SAFE strategy’ for trachoma elimination in Western Province, Zambia.," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .